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Abstract 
Background: Human constitution, the fundamental basis of oriental medicine, is categorized into different patterns 
for a particular disease according to the physical, physiological, and clinical characteristics of the individuals. Obesity, a 
condition of metabolic disorder, is classified according to six patterns in oriental medicine, as follows: spleen defi‑
ciency syndrome, phlegm fluid syndrome, yang deficiency syndrome (YDS), food accumulation syndrome (FAS), liver 
depression syndrome (LDS), and blood stasis syndrome. In oriental medicine, identification of the disease pattern for 
individual obese patients is performed on the basis of differentiation in obesity syndrome index and, accordingly, per‑
sonalized treatment is provided to the patients. The aim of the current study was to understand the obesity patterns 
in oriental medicine from the genomic point of view via determining the gene expression signature of obese patients 
using peripheral blood mononuclear cells as the samples.
Methods: The study was conducted in 23 South Korean obese subjects (19 female and four male) with BMI ≥25 kg/
m2. Identification of oriental obesity pattern was based on the software‑guided evaluation of the responses of the 
subjects to a questionnaire developed by the Korean Institute of Oriental Medicine. The expression profiles of genes 
were determined using DNA microarray and the level of transcription of genes of interest was further evaluated using 
quantitative real‑time PCR (qRT‑PCR).
Results and conclusion: Gene clustering analysis of the microarray data from the FAS, LDS, and YDS subjects exhib‑
ited disease pattern‑specific upregulation of expression of several genes in a particular cluster. Further analysis of 
transcription of selected genes using qRT‑PCR led to identification of specific genes, including prostaglandin endop‑
eroxide synthase 2, G0/G1 switch 2, carcinoembryonic antigen‑related cell adhesion molecule 3, cystein‑serine‑rich 
nuclear protein 1, and interleukin 8 receptor, alpha which were highly expressed in LDS obesity constitution. Our cur‑
rent study can be considered as a valuable contribution to the understanding of possible explanation for obesity pat‑
tern differentiation in oriental medicine. Further studies can address a novel possibility that the genomic and oriental 
empirical approaches can be combined and implemented in systematic and synergistic development of personalized 
medicine.
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Background
In recent years, DNA microarray, one of the most 
advanced techniques for profiling global gene expression, 
has emerged as a popular tool for investigation of human 
diseases as it enables comparison of gene expression pat-
terns between normal and pathological tissues and pro-
vides unique data about disease mechanisms, regulatory 
pathways, and gene functions [1–5].
Obesity is a kind of pathophysiological condition char-
acterized by excess accumulation of adipose tissue in the 
body, which is determined by genetic factors, overeating, 
inadequate physical activity, and improper lifestyle [6–8]. 
Obesity is also known to be a prime factor for increas-
ing the risk of other serious diseases, such as diabetes, 
hypercholesterolemia, fatty liver disease, hypertension, 
arteriosclerosis, angina, cardiac infarction, stroke, Pick-
wick syndrome, and gout [9]. Because of these facts, the 
mortality of obese patients is much higher than that of 
normal individuals [10–13]. In parallel with the current 
global scenario, obesity has become one of the most 
life-threatening problems in South Korea. The Korea 
National Health and Nutrition Examination reported 
that the overall prevalence of Korean adult obesity was 
30.7 % in 2008, compared with 21.8 % in 1998 [14].
Traditional medicine, which includes herbal medicine, 
acupuncture, and other non-medication therapies, repre-
sents a comprehensive system of medicine characterized 
by its inherent theoretical concept and practical experi-
ence [15]. Because of its unique prototype and remark-
able efficacy with fewer adverse side effects, this system 
of medicine has gained a considerable interest interna-
tionally. Oriental medicine, which is closely related to 
traditional Chinese medicine, focuses primarily on con-
stitutional approaches [15]. The term ‘body constitution’ 
(BC) is coined from the Chinese medicinal literature and 
culture to state one’s current health status which reflects 
the condition and function of his/her body [16]. More 
specifically, each constitution is categorized by the char-
acteristics of body shape, face, voice, and psychological 
and physiological aspects [17, 18], and those character-
istics differ between and among the constitutional types 
[19]. It has been stated that individuals representing 
different constitution types differ in their susceptibil-
ity to disease with a varied degree [20]. It has been also 
described that in general, a normal or balanced constitu-
tion represents an overall healthy state of an individual, 
whereas individuals with unbalanced constitutions are 
more susceptible to certain diseases [20, 21]. People 
can be classified into different types of body character-
istics such as strong, weak, ulcer, and bleeding types 
based on one’s risk or tendency of disease development 
[22]; and it has been opined that the relative risk of sev-
eral chronic diseases differs across different constitution 
groups [18, 23]. In other words, human constitutions can 
be categorized into different patterns for a particular dis-
ease depending on the physical, physiological, and clini-
cal characteristics of the individuals. Thus, in oriental 
medicine, subjects with disease are diagnosed based on 
the pattern identification [10], a comprehensive system 
characterized by its own theoretical basis and practical 
experience [24]. More specifically, the extensive analyses 
of symptoms and signs performed through this unique 
system have implications in determining the cause, 
nature, and location of the illness and the patient’s physi-
cal condition, and their treatment approaches [15]. In 
other words, pattern identification is used as a tool by the 
medical professionals of oriental medicine to diagnose 
patients, which ultimately allows personalized treatments 
according to the symptoms of individual patients.
In oriental medicine, obesity is considered a disease 
state of humans, who are categorized as ‘Obese People,’ 
Soft Extratic People,’ or ‘Flesh People.’ [25] Six disease 
patterns in obesity among the Korean population have 
been identified and implemented by the Korea Institute 
of Oriental Medicine (KIOM, Daejeon, South Korea) 
[26]. These are categorized as spleen deficiency syn-
drome (SDS), phlegm fluid syndrome (PFS); yang defi-
ciency syndrome (YDS); food accumulation syndrome 
(FAS), also termed as indigestion or food stagnation syn-
drome; liver depression syndrome (LDS) or stagnation of 
liver qi syndrome; and blood stasis syndrome (BSS) [15]. 
Doctors practicing oriental medicine make a diagnosis 
of obese patients on the basis of differentiation in obe-
sity syndrome index and accordingly identify the disease 
pattern and prescribe medicines, providing personalized 
treatment to the patients. In the field of western medi-
cine, in general, individual patterns are not considered 
in diagnosis of diseases and prescription of medicines to 
patients. In contrast, the oriental medicine field follows 
inherent or empirical traits of patients, sometimes result-
ing in better medicinal impact with fewer adverse side 
effects [26–28].
In the current study, we attempted to evaluate the ori-
ental obesity patterns from the genomic point of view 
This clinical trial was registered in Clinical Research Information Service of Korea National Institute of Health (https://
cris.nih.go.kr/cris/index.jsp). Registration number: KCT0000387
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via determining the expression profiles of genes using 
DNA microarray and quantitative real-time PCR (qRT-
PCR) techniques. Microarray-based techniques have 
been adopted previously for identification of the pat-
tern of gene expression in traditional medicinal consti-
tutions [29, 30]. In our study, gene clustering analysis of 
the microarray data of subjects representing FAS, LDS, 
and YDS patterns exhibited enriched expression profile 
of several genes. In addition, subsequent analysis of tran-
scription of selected genes using qRT-PCR led to identi-
fication of marker genes that are highly expressed in LDS 
obesity constitution. Although our study did not catego-
rize all oriental obesity patterns from the genomics point 
of view, it made a valuable contribution to the classifica-
tion and acquisition of specific marker genes signifying 
an empirical science based oriental obesity pattern.
Methods
Subjects
The scientific investigation reported here was an addi-
tional study of a clinical trial conducted in Dongguk 
University Oriental Hospital, South Korea [registered in 
Clinical Research Information Service of Korea National 
Institute of Health, (https://cris.nih.go.kr/cris/index.jsp), 
registration number: KCT0000387]. Briefly, 166 obese 
subjects were enrolled for the main trial who responded 
to an advertisement that explained the purpose of the 
study. They were provided with a brief outline of the 
trial along with the exclusion criteria. The recruitment 
procedure was continued for more than a year (Octo-
ber, 2009 to November, 2010). From the entire pool of 
the participants, 23 subjects (19 females and 4 males) 
were randomly chosen for the present microarray study. 
Additional obese subjects were also selectively or ran-
domly chosen from the volunteer pool to provide sam-
ples for comparative gene expression analysis. To comply 
with this study, subjects should be ethnically Korean and 
within 18 to 65-years-of-age. They should be non-smoker 
and must possess in-general good physical condition 
with BMI ≥25 kg/m2. Their body weight should not have 
changed within ±3  kg during the last 3  months. Prior 
to the trial, all screened volunteers were informed in 
detail of the purpose and principles of the study, and the 
freedom to withdraw from the study. The subjects were 
then instructed to peruse the consent forms provided to 
them and sign the forms if they agreed to participate in 
the trial. Following this, the general health conditions of 
the volunteers were evaluated by a physician. The follow-
ing abnormal health conditions were considered among 
the exclusion criteria: heart, renal, or hepatic disease, 
history of alanine aminotransferase (ALT) or aspartate 
aminotransferase (AST) enzyme activity >2.5 times the 
normal upper limit, or level of creatinine >2.0 mg/dL, as 
well as malignancy. In addition, subjects under medica-
tions that may interfere with the body composition and 
metabolism, and subjects who had exhibited a hypersen-
sitive reaction to a drug were excluded. Pregnancy at any 
time point during the study period was also among the 
exclusion criteria. The trial was initiated following the 
approval of the medical, scientific, and ethical aspects of 
the study by the Institutional Review Board of Dongguk 
University Oriental Hospital (09-CR-12).
Identification of oriental obesity pattern
A computer-based self-reporting online questionnaire 
developed by Korean Institute of Oriental Medicine 
(KIOM, Daejeon, South Korea) was used for identifica-
tion of oriental obesity pattern of the subjects (http://
ammrc.kiom.re.kr/renewal/obesity/). During their first 
visit to the hospital, the subjects were asked to enter their 
responses to the queries depicted in the online form. 
The software program developed by KIOM analyzes the 
responses in the questionnaire and based on these des-
ignates every subject as one out of existing six obesity 
patterns in oriental medicine, as follows: SDS, PFS, YDS, 
FAS, LDS, and BSS. This questionnaire consists of 52 
questions: 8 questions about general or systemic symp-
toms; 8 on personality and emotion, 18 on digestive func-
tion and 18 on circulatory function (see Additional file 1: 
Table S1 for further details). Each question which has 
different weight according to its significance for pattern 
diagnosis is valued on a 5-point scale (1, little; 2, mild; 3, 
moderate; 4, intensive; 5, very intensive). The software 
automatically calculates the points for each question 
after a logical evaluation of the relative significance of 
the response against the function under which the ques-
tion belongs. Based on the points accumulated through 
the subject’s responses to the questionnaire, the KIOM 
software computes and assigns the score for each ori-
ental obesity pattern. Finally, each subject is designated 
by a pattern which obtains the highest score among the 
six patterns in that particular subject. This questionnaire 
has been validated in several studies measuring the cred-
ibility and reliability [26, 28, 31, 32]. The agreement rate 
between the obesity patterns diagnosed by experts in the 
field of obesity in oriental medicine and the pattern diag-
nosis generated by the KIOM questionnaire was investi-
gated [26, 28]. The reported Cronbach alpha coefficient 
ranged from 0.720 to 0.848.
Isolation of PBMCs
Shortly after their enrolment, blood was collected from 
the subjects following standard protocol. PBMCs were 
isolated from the whole heparinized blood by standard 
gradient centrifugation using Ficoll-Paque Plus reagent 
(GE Healthcare, Little Chalfont, Waukesha, WI, USA) 
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according to the manufacturer’s instruction. Briefly, 
8  mL of whole blood was diluted with phosphate-buff-
ered saline (PBS, pH 7.4) and added carefully to the tube 
filled with 15  mL of Ficoll-Paque plus reagent. PBMCs 
were then separated into soluble interface between the 
upper plasma layer and lower Ficoll layer by centrifug-
ing the samples at 400×g for 30 min at room temperature 
followed by collection of the resulting PMBC layer. The 
isolated PBMC fractions were washed twice by centrifu-
gation at 100×g for 10  min at room temperature using 
PBS.
RNA preparation and DNA microarray
Total RNA of the PMBCs was extracted using TRI rea-
gent (Ambion, Austin, TX, USA) and the RNeasy mini 
kit (Qiagen, Hilden, Germany) following the reagent and 
kit manufacturer’s instructions, respectively. The yield 
of RNA ranged from 5.02 to 15.37  μg with an average 
of 8.85 μg. The integrity of extracted RNA was verified 
by gel electrophoresis. DNA microarray of the samples 
and subsequent analysis of the data were performed as 
described previously [33]. Briefly, 5 μg of total RNA was 
reverse transcribed for generation of double-stranded 
cDNA (dscDNA) using a SuperScript double-stranded 
cDNA synthesis kit (Invitrogen, Carlsbad, CA, USA). 
Reactions were terminated by addition of EDTA followed 
by RNase A treatment. Samples were then subjected to 
ethanol-precipitation and finally rehydrated to make the 
stock solution of dscDNA at a concentration of 250 ng/
μl. Next, 1 μg dscDNA was labeled with Cy3-conjugated 
random 9-mer (TriLink Biotechnologies, San Diego, CA, 
USA) using Klenow fragment (NEB, Beverly, MA, USA); 
the labeled samples were then subjected to isopropanol 
precipitation. Four micrograms of Cy3-labeled DNA 
(containing sample tracking control and alignment oligo) 
was then hybridized to NimbleGen, 12-plex, human 
microarray slides (Human Gene Expression 12 × 135 K 
Microarray, NimbleGene, Madison, WI, USA) for 18 h at 
42 °C using the NimbleGen Hybridization system (Nim-
bleGen). Subsequently, the array slides were washed by 
vigorous agitation in 1 × SSC + 0.1 % SDS for 5 min at 
55 °C and in 0.1 × SSC + 0.1 % SDS for 5 min at room 
temperature. The slides were then rinsed with distilled 
water and dried by centrifugation. The array images 
were captured using an InnoScan 900 Series Microarray 
Scanner (Innopsys, Carbonne, France) and the signals 
extracted from the scanned images were then imported 
into NimbleScan software (version 2.5, Nimblegen) for 
grid alignment and analysis of gene expression data. 
Expression data were normalized using a quantile nor-
malization method [34] and Robust Multichip Average 
(RMA) algorithms [34]. Gene ontology (GO) analysis 
was performed using the software toolkit provided in the 
web-accessible Database for Annotation, Visualization, 
and Integrated Discovery (DAVID) programs (http://
niaid.abcc.ncifcrf.gov/home.jsp) [35]. For this analysis, 
the selected gene list was uploaded into the program and 
the gene list of Nimblegen microarray chip was used as 
the background. For clustering analysis, data from micro-
array was uploaded to the Cluster program and cluster 
analysis was performed by applying parameters of inter-
est, as described previously [36]. Clustered data were vis-
ualized using the TreeView program.
Quantitative real‑time PCR (qRT‑PCR)
Total RNA of the PMBCs was extracted using TRI rea-
gent (Ambion) according to the reagent manufacturer’s 
instructions; 500  ng of RNA was processed for cDNA 
synthesis using the high capacity cDNA reverse tran-
scription kit (Applied Biosystems, Foster City, CA, USA) 
following the instructions provided by the kit manufac-
turer. qRT-PCR of the samples was performed in a Ste-
pOne™ real-time PCR system (Applied Biosystems). 
The primer sequences used in our experiment were as 
follows: NM_000634 forward, 5′-ACC TGG CCG GTG 
CTT CAG TTA G-3′ and reverse, 5′-TCC CAG CAG 
GCT CAG CAG GAA-3′; NM_000963 forward, 5′-TTG 
CCC GAC TCC CTT GGG TGT-3′ and reverse, 5′-AAG 
TCC ACC CCA TGG CCC AGC-3′; NM_001815 for-
ward, 5′-CAC CAA TGC ATC CCT GCT GAT CCA-3′ 
and reverse, 5′-GCT GGT TCT TCC AGT TTT GGC 
AAG G-3′; NM_015714 forward, 5′-GCG CCG TGC 
CAC TAA GGT CAT TC-3′ and reverse, 5′-AGA CGT 
CTG GCG GCC GTG AA-3′; NM_033027 forward, 
5′-GCA GTG GAA GCT TTC GGC AGC-3′ and reverse, 
5′-AGC TCC CGC TTC TCC TCC CG-3′.
The following conditions were applied for the PCR 
amplification reactions: an initial incubation step at 95 °C 
for 2 min, followed by 40 amplification cycles, each one 
consisting of a denaturation step at 95  °C for 10  s, an 
annealing step at 60 °C for 10 s, and an extension step at 
72  °C for 30  s. Following this reaction, a melting curve 
analysis was performed in order to verify the specific-
ity of the amplicon. The StepOne™ Real-Time PCR 
Systems software supplied by the instrument manufac-
turer (Applied Biosystems) was used for processing and 
analysis of the data. Diluted aliquots (1/10, 1/100) of the 
cDNA reaction mixture were analyzed for generation of 
a standard curve. Relative amount of mRNA was quanti-
fied using the freshly prepared standard curve.
Statistical analyses
Results are expressed as the mean ±  standard deviation 
(SD). All statistical analyses were performed using SPSS 
software (Version 20, SPSS Inc, Chicago, IL, USA). One-
way ANOVA was used for comparison of differences 
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among the three oriental obesity patterns. Independ-
ent student’s t test was used for comparison of differ-
ences between two groups. Correlations between clinical 
parameters and the level of gene expression were assessed 
by Pearson’s correlation test. To determine correlation 
values, heat map analyses were performed using Permut-
Matrix software (Version 1.0.3 EN, PermutMatrix, Mont-
pellier, France). P value <0.05 was considered statistically 
significant. As mentioned above, gene ontology (GO) 
term enrichment was analyzed using tools available on 
the DAVID website [35] and data from ‘GOTERM_BP_
ALL’ database are presented in Table 1.
Results
Anthropometric and body composition parameters, 
and oriental obesity patterns of the subjects
The identification numbers, age, sex, general char-
acteristics, anthropometric and body composition 
parameters, and oriental obesity patterns of the 23 
subjects (19 females and 4 males) involved in the pre-
sent microarray study are shown in Table  2. Among 
the subjects, 9 showed symptoms of LDS (3 males 
and 6 females), 8 exhibited FAS pattern (1 male and 
7 females) and 6 showed symptoms of YDS (all were 
females) (Table  3). Statistical analysis using one-way 
ANOVA revealed no significant differences in the 
obesity-related parameters among these three disease 
patterns (Table  3). However, since there are possibili-
ties that age and sex of the subjects might influence 
the bias, we further extended our statistical evalu-
ation using ANCOVA being adjusted by these two 
parameters as covariates. The results reconfirmed no 
significant differences in the obesity-related param-
eters (Table  3), consistent with our ANOVA analysis. 
This assures that in our study, the selection bias was 
minimized by appropriate randomization. Further, 
to judge whether the distributions of TG and HDL-C 
might be skewed, we also carried out the non-para-
metric method of Kruskal–Wallis test for these two 
parameters. The analysis (P values: 0.722 and 0.319 for 
TG and HDL-C, respectively) did not show any differ-
ence from our evaluation using parametric method.
Validation of specific syndrome differentiation by gene 
clustering of the obese patients
DNA microarray analysis of the PMBC of the subjects 
showed no marked difference in the average expression 
of the probes on the array among the three syndrome 
indexes mentioned above (Fig.  1), indicating that the 
quality of the performed microarray assay was satisfac-
tory. When we performed the gene clustering analysis, 
those three oriental obesity patterns were categorized 
into three entities (Fig. 2). We explored various filtering 
conditions for clustering analysis. In most of these tested 
filtering conditions, clustering of genes in a syndrome 
index-dependent manner was found. Here we present 
the clustering results based on one of the filtering con-
ditions as described above where we observed optimum 
syndrome index dependency. More specifically, three 
marked classifications were evident when whole genes 
were filtered according to a specific condition (at least 
one observation with value ≥2.0), similarity metric [cor-
relation (centered)] and clustering method (centroid link-
age). The categories were further divided into two parts. 
One part was comprised of seven subjects among whom 
five (71 %) represented LDS pattern (A) and two (29 %) 
belonged to the FAS pattern type (Fig.  2). The other 
part representing the remaining 16 subjects was fur-
ther divided into two groups. One group consisted of 10 
subjects among whom five represented the FAS pattern 
Table 1 Gene ontology analysis of cluster 1
Biological terms Count % P‑value Bonferroni Benjamini False discovery rate (FDR)
Defense response 31 18.24 5.17E−13 6.85E−10 6.85E−10 8.46E−10
Inflammatory response 19 11.18 5.27E−09 6.99E−06 3.50E−06 8.63E−06
Response to wounding 22 12.94 9.11E−08 1.21E−04 4.03E−05 1.49E−04
Behavior 20 11.76 2.84E−07 3.76E−04 9.40E−05 4.64E−04
Chemotaxis 12 7.06 7.09E−07 9.40E−04 1.88E−04 0.001161
Taxis 12 7.06 7.09E−07 9.40E−04 1.88E−04 0.001161
Immune response 23 13.53 1.78E−06 0.00236013 3.94E−04 0.002917
Response to bacterium 11 6.47 2.81E−05 0.03663204 0.00531722 0.046055
Locomotor behavior 12 7.06 1.14E−04 0.14035727 0.01872723 0.186507
Female pregnancy 7 4.12 9.08E−04 0.70026536 0.12529893 1.476213
Learning or memory 7 4.12 9.52E−04 0.7172579 0.118669 1.547164
Defense response to bacterium 7 4.12 9.98E−04 0.73386108 0.11338081 1.62068
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(50  %, B) and the other group consisted of six subjects 
among whom four (67 %) exhibited the YDS pattern (C).
Identification of differentially expressed genes (DEGs) 
in specific oriental obesity pattern
For identification of gene sets that are presumed to be 
differentially regulated among the classified oriental 
obesity patterns, we performed further gene clustering 
analysis using the microarray data. As shown in Fig.  2, 
significant gene sets for each pattern were not detected 
when all gene expression profiles of 23 subjects were 
processed for clustering analysis. This result suggests 
that each pattern may consist of subtype patterns which 
differ from each other in their gene expression profiles. 
In this regard, we narrow down numbers of expression 
profiles based upon clustering results in Fig. 2. More spe-
cifically, we performed gene clustering analysis using the 
microarray data of commonly upregulated genes from 
the categorized five subjects of LDS (A), five subjects of 
FAS (B), and four subjects of YDS patterns (C), as men-
tioned above (Fig. 2). A total of 382 genes were subjected 
to clustering analysis (Fig. 3a, left panel, the list of genes 
is depicted in Additional file 2: Table S2) which ultimately 
revealed that among these genes, 176 were specifically 
clustered (cluster 1).
Our analysis also demonstrated that cluster 1 was sig-
nificantly upregulated (P < 0.0001) only in subjects rep-
resenting LDS pattern compared to volunteers belonging 
to FAS and YDS pattern types (Fig. 3a, left panel, Fig. 3b). 
According to gene ontology analysis, genes that were 
highly enriched in this cluster were found to be related to 
defense response against pathogens or chemical insults 
(Table 1). Next, from all of the genes grouped in cluster 
1, we sorted a total of 14 genes that were commonly up-
regulated in LDS subjects (Fig. 3a, right panel). The iden-
tification number and name of these genes are shown 
in Table  4. Correlation between these 14 genes and the 
Table 3 Baseline characteristics of  the three most frequent oriental obesity patterns: yang deficiency syndrome (YDS), 
food accumulation syndrome (FAS), and liver depression syndrome (LDS)
Data are shown as Mean ± SD
P value: One-way ANOVA was used for cross-sectional comparison among three groups
P2 value: P value from ANCOVA adjusted by age and sex
BW body weight, BMI body mass index, MR metabolic rate, WC waist circumference, FP fat percentage, TBF total body fat, FBS fasting blood sugar, TG triglyceride, HDL 
high density lipoproteins, T. chol total cholesterol, sBP systolic blood pressure, dBP diastolic blood pressure, PR pulse rate
Gender YDS (n = 6) LDS (n = 9) FAS (n = 8) Total (n = 23) P value P2 value
Male = 0/Female = 6 Male = 3/Female = 6 Male = 1/Female = 7 Male = 4/Female = 19
Age (years) 44.7 ± 9.20 40.9 ± 9.47 37.3 ± 5.15 40.6 ± 8.30 0.262
BW (kg) 71.9 ± 4.81 79.3 ± 9.28 75.6 ± 8.46 76.1 ± 8.28 0.650 0.764
BMI (kg/m2) 28.4 ± 1.44 29.4 ± 1.80 28.3 ± 1.34 28.8 ± 1.58 0.670 0.843
MR (kcal/day) 1451.7 ± 325.54 1615.6 ± 428.34 1528.8 ± 348.44 1542.6 ± 365.98 0.635 0.752
WC (mm) 95.8 ± 3.42 99.6 ± 6.77 95.3 ± 5.73 97.1 ± 5.83 0.619 0.484
FP (%) 38.9 ± 3.68 35.5 ± 5.43 38.2 ± 6.38 37.3 ± 5.39 0.809 0.067
TBF (%) 27.9 ± 3.16 28.2 ± 3.48 28.7 ± 4.67 28.3 ± 3.70 0.741 0.051
FBS (mg/dL) 98.2 ± 6.65 96.8 ± 10.38 95.1 ± 10.51 96.6 ± 9.26 0.473 0.848
TG (mg/dL) 116.8 ± 54.29 129.1 ± 56.19 111.8 ± 38.83 119.9 ± 48.57 0.418 0.590
HDL (mg/dL) 81.0 ± 51.57 54.3 ± 21.17 55.0 ± 16.92 61.5 ± 31.60 0.126 0.545
T.Chol (mg/dL) 202.5 ± 38.30 207.8 ± 56.69 186.5 ± 26.08 199.0 ± 42.55 0.197 0.162
sBP (mmHg) 133.2 ± 9.91 125.1 ± 10.20 121.4 ± 10.23 125.9 ± 10.75 0.994 0.707
dBP (mmHg) 79.3 ± 6.25 80.0 ± 5.02 79.8 ± 5.06 79.7 ± 5.13 0.600 0.832
PR (/min) 76.5 ± 10.15 73.1 ± 10.86 71.3 ± 7.72 73.3 ± 9.47 0.711 0.972
Fig. 1 Whole gene expression of subjects representing three distinct 
oriental obesity patterns (LDS, FAS, and YDS). The average gene 
expression profile from nine subjects of LDS, eight of FAS and six of 
YDS patterns are represented by box plot (each showing 5th, 25th 
50th, 75th, and 95th percentiles)
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obesity parameters of the aforementioned 14 subjects as 
analyzed by heatmap plots is shown in Fig. 4. To deter-
mine whether the increase in expression of these 14 genes 
in LDS pattern was significant, we sorted them from 
the microarray data set of those 14 individuals and per-
formed statistical analysis using student’s t-test. Accord-
ingly, our data showed that among those 14 selected 
genes, the expression of 10 genes was significantly higher 
in LDS obesity pattern compared to FAS and YDS pat-
terns (Fig. 5).
Confirmation of higher expression of particular genes 
in specific oriental obesity pattern
Next, we made an effort to further validate the higher 
expression of the identified 10 marker genes mentioned 
above in LDS obese patients (Fig. 5). For this, we selected 
five genes (NM_000963, prostaglandin endoperoxide 
synthase 2, PTGS2; NM_015714, G0/G1 switch 2, G0S2; 
NM_001815, carcinoembryonic antigen-related cell 
adhesion molecule 3, CEACAM3; NM_033027, cystein-
serine-rich nuclear protein 1, CSRNP1; and NM_000634, 
interleukin 8 receptor, alpha, CXCR1) as representatives 
and measured their expression individually by quan-
titative RT-PCR using PBMC samples of the subjects. 
In this experiment, 15 LDS PBMC samples and 15 ran-
domly selected PBMC samples (for PTGS2 and G0S2), 
and 10 LDS PBMC samples and 10 randomly selected 
PBMC samples (for CEACAM3, CSRNP1, and CXCR1) 
collected from the additional subjects were used for the 
gene expression profiling. The age, gender, and the clini-
cal features of these subjects are depicted in Additional 
file  3: Table S3 and Additional file  4: Table  S4, respec-
tively. As shown in Fig. 6 and Additional file 5: Figure S1, 
significantly higher expression of all of the above men-
tioned five genes was observed in the LDS obese patients 
compared to the randomly selected obese subjects. Fur-
ther to examine whether the distribution of the relative 
mRNA level of PTGS2 might be skewed, we carried out 
the statistical analysis of this parameter using non-para-
metric method of Mann–Whitney’s U test. The analysis 
further confirmed significantly higher PTGS2 expression 
in LDS compared to random samples (P = 0.03). The rel-
ative expression of PTGS2 and G0S2 genes in the 15 LDS 
and 15 randomly selected subjects are depicted individu-
ally in Additional file  6: Table  S5 and Additional file  7: 
Table S6, respectively.
Discussion
Obesity, which was officially considered a disease by 
the World Health Organization (WHO) in 1997 [37], 
is a serious and alarming global public health prob-
lem. Accumulating evidence suggests that obesity can 
increase the risk of many other life-threatening diseases, 
including certain types of cancers. WHO predicts that 
Fig. 2 Classification of three distinct oriental obesity patterns based on gene clustering analysis. Whole genes and arrays (three oriental obesity 
patterns: LDS, FAS, and YDS) were filtered and clustered following a specific condition (at least one observation with value >−2.0), similarity metric 
[Correlation (centered)] and clustering method (centroid linkage). Clusters of genes or arrays are represented by Treeview
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Fig. 3 Identification of oriental obesity pattern specific genes. a 382 filtered genes of five subjects of LDS, five subjects of FAS, and four subjects of 
YDS patterns were clustered and represented by Treeview following a specific condition (at least one observation with value ≥2.0), similarity metric 
[correlation (centered)] and clustering method (centroid linkage). Cluster 1 represents classified genes specifically upregulated in LDS. A total of 14 
genes that were commonly upregulated in LDS pattern were sorted out from cluster 1 (right panel). b Expression of cluster 1 genes is represented 
by box plot (each showing 15th, 25th, 50th, 75th, and 95th percentiles). P‑value was determined using one‑way ANOVA analysis (***P < 0.0001)
Table 4 Gene ID and description of 14 sorted genes
Gene ID Gene name
NM_170776 G protein‑coupled receptor 97 (GPR97)
NM_015714 G0/G1 switch 2 (G0S2)
NM_001815 Carcinoembryonic antigen‑related cell adhesion molecule 3 (CEACAM3)
NM_019099 Chromosome 1 open reading frame 183 (FAM212B)
NM_024565 Cyclin J‑like (CCNJL)
NM_033027 Cystein‑serine‑rich nuclear protein 1 (CSRNP1)
NM_001082 Cytochrome P450, family 4, subfamily F, polypeptide 2 (CYP4F2)
NM_001964 Early growth response 1 (EGR1)
NM_005306 Free fatty acid receptor 2 (FFAR2)
NM_000634 Interleukin 8 receptor alpha (CXCR1)
NM_052972 Leucine‑rich alpha‑2‑glycoprotein 1 (LRG1)
NM_004148 Ninjurin 1 (NINJ1)
NM_000963 Prostaglandin‑endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase, PTGS2)
NM_024075 tRNA splicing endonuclease 34 homolog Saccharomyces cerevisiae (TSEN34)
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approximately 2.3 billion adults in the global population 
will be overweight by 2015 and 700 million of them will 
be obese [38]. Notably, obesity is also becoming a major 
concern in South Korea as The Korea National Health 
and Nutrition Examination Survey reported an overall 
incidence of Korean adult obesity of 30.7 % in 2008, com-
pared with 21.8 % in 1998 [14].
In the entire human population, each individual has his 
or her own entity, which differs from that of others. The 
fundamental concept in the practice of oriental medicine 
is based on the human constitution, which is classified 
according to the physical, physiological, and clinical char-
acteristics of the individual. According to this concept, 
individuals from different constitutional patterns differ in 
their metabolic pattern and susceptibility to disease with 
a varying degree. As a norm, clinicians in oriental medi-
cine focus on evaluation of the cause, nature, and loca-
tion of the disease according to the signs and symptoms 
shown by the patients [12], and, based on this informa-
tion prescribe individualized treatment to the patients 
[15]. Interestingly, emerging scientific evidence indi-
cates a genetic basis for oriental medicine, where it has 
been opined that further investigations using up to date 
Fig. 4 Analyses of correlation between the selected genes and obe‑
sity parameters using a heat map. As the color scale is shown, green 
color indicates a negative correlation, while red color indicates a posi‑
tive correlation (a symbol of asterisk indicates statistical significance 
of P < 0.05)
Fig. 5 Expression of 14 selected genes in 14 subjects represented by LDS (five subjects), FAS (five subjects), and YDS (four subjects) patterns. The 
selected 14 genes were sorted out from each individual DNA microarray data of the subjects and their expression level was compared between 
subjects of LDS and FAS and YDS in combination. P‑values were determined using student’s t‑test (N.S. not significant; *P < 0.01, **P < 0.001)
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genomic tools could help to introduce oriental medicine 
as an alternative to personalized treatment practiced in 
western medicine.
In general, oriental obesity patterns are clinically 
judged by the oriental medical doctors on the basis of the 
patient’s current symptoms, personality, digestive or cir-
culatory conditions. According to the Korea Institute of 
Oriental Medicine, among the Korean population, there 
are six disease patterns in obese people [26], as follows: 
SDS, PFS, YDS, FAS, LDS, and BSS. Although the pat-
tern identification is regarded as rather empirical from 
the scientific point of view, the questionnaire for obesity 
pattern identification has been validated in various stud-
ies [26, 28, 31, 32]. In general, SDS represents a condition 
for deficiency of the spleen, such as spleen qi deficiency, 
spleen yang deficiency, and spleen yin deficiency [15]. 
PFS depicts (1) a condition for retention of phlegm and 
fluid in any part of the body; (2) a particular state for 
retention of fluid in the gastrointestinal tract, e.g., gastric 
retention in pyloric stenosis (WHO). YDS represents a 
pathological condition characterized by deficiency of the 
body’s yang qi, which leads to abatement of functions, 
decline in metabolic activity, and decreased body reac-
tions as well as deficiency-cold manifestations [15]. FAS 
denotes a pattern/syndrome marked by epigastric and 
abdominal distention, vomiting of sour matter, anorexia, 
offensive odor of stools, and curdy and slimy tongue 
coating [15]. LDS represents a state of stagnation of qi in 
the liver caused by impairment of free coursing [15]. BSS 
denotes a morbid condition of blood stagnancy in a par-
ticular area of the body resulting from sluggish flow of qi, 
deficiency of qi or blood, trauma, or yin-cold [15].
Inter-individual genetic differences in the human popu-
lation, which are bestowed by a number of factors, such 
as single nucleotide polymorphisms [39], copy number 
variations [40], and epigenetic or gene expression modi-
fications [41–43], play a vital role in the contribution to 
phenotypic variations. These variations influence an indi-
vidual’s anthropometric parameters as well as suscepti-
bility to disease and response to the environment [44]. 
Therefore, in-depth study of genetic variation may facili-
tate understanding of the mechanisms underlying differ-
ential risk of disease and response to drugs in the human 
population. Indeed, rapid progress in ‘omics’ sciences has 
opened a new horizon in traditional medicine research. 
Accordingly, considerable interest has been paid world-
wide, including Korea, India, China, and Japan to studies 
for understanding the genomic, proteomic, and metabo-
lomic basis of disease patterns.
In recent years, DNA microarray has emerged as a pop-
ular technique for investigation of human diseases since 
it provides unique data about disease mechanisms, regu-
latory pathways, and gene functions [44]. Microarrays 
have been employed for investigation of several patho-
logical conditions, such as inflammation, atherosclero-
sis, breast cancer, colon cancer, and pulmonary fibrosis 
[45]. In parallel, microarray-based techniques have also 
been applied in earlier studies to characterize the mode 
of gene expression in traditional medicinal constitu-
tions and disease patterns. An earlier study attempted to 
address a scientific approach for oriental medicine treat-
ment by combining oriental therapy for obesity, such as 
oral administration of Ephedra sinica extract or Sinome-
nium acutum extract, and western techniques including 
DNA microarray [46]. However, the empirical and inher-
ent properties of oriental medicine are not well under-
stood, which prompted us to conduct the current study, 
where we performed DNA microarray analysis using 
PBMC samples from obese patients in order to catego-
rize specific symptoms in accordance with oriental obe-
sity patterns.
In this study, we acquired genome-wide transcrip-
tion profiles of 23 subjects who represented the three 
most frequent oriental obesity pattern types: FAS, LDS, 
Fig. 6 Expression levels of endogenous PTGS2 and G0S2 genes in 15 randomly selected subjects (Random) or 15 volunteers representing LDS pat‑
tern (LDS) were measured using quantitative RT‑PCR. The data are represented by scatter plot. P‑value was determined using student’s t‑test
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and YDS. According to our microarray data, no marked 
difference in the average expression of the probes on 
the array was evident among the three obesity patterns 
mentioned above (Fig.  1), indicating that the quality of 
the performed microarray assay was high. When the all 
genes and array data were filtered and clustered following 
a specific condition, the subjects were agglomerated into 
three main categories represented by LDS, FAS, and YDS 
patterns, respectively. Thus, our results may be consid-
ered as an evidence-based approach addressing a possible 
molecular explanation for obesity pattern differentiation 
which is normally practiced in oriental medicine.
A number of recent studies have been conducted to 
understand the possible genetic explanation for the dif-
ferentiated constitution types or disease patterns in tra-
ditional medicine. These include a microarray survey 
which identified 785 up-regulated genes and 954 down-
regulated genes in YDS in comparison with normal con-
stitution [29]. In another study, analysis of genome wide 
expression through cDNA microarrays revealed a num-
ber of differentially expressed genes in each category of 
individuals from the three most contrasting constitution 
types (Vata, Pitta, and Kapha) as defined by Ayurveda-
based method in India [30]. On the other hand, genes 
such as angiotensin I converting enzyme, parathyroid 
hormone, tumor necrosis factor, CD4, glucose phosphate 
isomerase, C-reactive protein, and vascular endothelial 
growth factor have been found to show strong relation-
ships with Kidney-Yang Deficiency syndrome [47].
We further performed gene clustering analysis using 
the microarray data of commonly categorized five sub-
jects representing LDS, five subjects exhibiting FAS, and 
four subjects of the YDS. As a result, 176 genes were 
clustered (cluster 1) and showed significant up-regula-
tion (P  <  0.0001) in subjects representing LDS pattern 
compared to subjects belonging to FAS and YDS pattern 
types, suggesting that stagnation of qi in the liver may 
contribute to the etiology of obesity. Indeed, liver stag-
nation, which is generally caused by prolonged strong 
emotions or depression, leads to disharmony between the 
spleen and liver, ultimately giving rise to fluid retention 
[48]. Because liver becomes depressed in this condition, 
the gall bladder is also depressed and exhausted. As a 
result, the ebb and flow of these organs become unbal-
anced, and the qi mechanism does not flow freely. As a 
consequence, transformation of fat turbidity becomes 
difficult and over the course of time the condition leads 
to obesity [48].
In an earlier study, 12 proteins were differentially 
expressed in the serum of patients with liver stagnation 
syndrome, compared with the normal control group [49]. 
Further analysis revealed that these differential proteins 
were mainly related to immunization, neuroendocrine 
and nutrient metabolism. While, in our study, gene 
ontology analysis of microarray data demonstrated 
that in cluster 1, where all 176 genes were signifi-
cantly upregulated in LDS, the genes related to defense 
response against pathogens or chemical insults were 
highly enriched, suggesting a possible functional role of 
these genes in response to the onset and development of 
liver stagnation. As liver is involved in neutralization and 
detoxification of harmful chemicals or pathogens, the up-
regulation of defense-system related genes in LDS is not 
an unexpected phenomenon.
For more extensive analysis of our microarray data, we 
sorted 14 genes from the aforementioned cluster 1 that 
were commonly up-regulated in LDS. Results showed 
that expression of 10 of those 14 genes was significantly 
elevated in LDS compared to FAS and YDS patterns. 
Correlation between these 14 genes and the obesity 
parameters of the aforementioned 14 subjects as ana-
lyzed by heatmap plots is shown in Fig. 4. Most notable 
finding in correlation analysis was that among 14 up-reg-
ulated genes in LDS subjects, 6 genes showed significant 
correlation with systolic blood pressure and most of the 
genes except NM024075 (TSEN34) displayed a tendency 
of negative correlation. It is widely known in oriental 
medicine that LDS, or liver qi stagnation in other word, 
is related to chronic restraint of stress [50, 51] which ulti-
mately leads to liver disease and stress related symptoms 
including high blood pressure. Although these genes 
have not yet found to have a direct effect on blood pres-
sure, this may provide a reasonable evidence for oriental 
medical theory on which further study will be needed.
Our further study revealed that the expression of five 
representative members of these 10 genes (NM_000963, 
PTGS2; NM_015714, G0S2; NM_001815, CEACAM3; 
NM_033027, CSRNP1; and NM_000634, CXCR1) as 
determined by quantitative RT-PCR was significantly 
higher in LDS obese patients compared to randomly 
selected samples. Notably, a number of studies have 
reported the impact of PTGS2 and G0S2 genes on hepatic 
function and pathophysiology. The cyclooxygenases 
2-prostanoid pathway has been reported to play vital and 
complex roles in pathogenesis of various liver diseases 
[52]. A number of studies have indicated that the COX2-
prostanoid pathway may inhibit hepatic fibrogenesis by 
decreasing proliferation, migration, and contractility of 
hepatic stellate cells [52]. On the other hand, recent stud-
ies have reported that targeted disruption of G0S2 alters 
hepatic energy balance [53] and overexpression of this 
gene induces triglyceride accumulation in the mouse liver 
leading to development of hepatic steatosis [54]. While 
emerging evidence indicates possible linkage between 
CXCR1, CEACAM3, and CSRNP1 genes and liver func-
tion. CXCR1 represents the cellular targets of IL-8 [55] 
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which is known to be involved in the pathogenesis of 
chronic liver disease. Furthermore, it has been reported 
that CXCR1 expression is induced in hepatocytes after 
ischemia/reperfusion (I/R) injury [56]. The results sug-
gests that CXCR1 facilitates repair and regenerative 
responses of liver after I/R injury. It has been found that 
CXCR1/CXCR2 ligands promote neutrophil migration to 
the liver and regulate hepatocyte survival and prolifera-
tion [57]. CEACAM3 belongs to CEACAMs which are 
a group of mammalian immunoglobulin related glyco-
proteins. They play an important role in cell–cell recog-
nition and modulation of cellular processes such as the 
shaping of tissue architecture and neovascularization, as 
well as regulation of hepatic insulin sensitivity by facili-
tating insulin metabolism in liver [58, 59]. Accumulating 
evidence indicates that CEACAM3 is critically involved 
in the opsonin-independent recognition and elimina-
tion of several Human-specific bacterial pathogens [60, 
61]. Considering the above findings on LDS together, our 
study can be considered as a probable molecular explana-
tion of pattern-specific pathophysiological condition cat-
egorized in oriental obesity medication.
Our study has some limitations. First, although our 
study can be considered as exploratory, the number of 
subjects in the present microarray-based study is not 
large. Data based on larger samples are scientifically 
more valid compared to smaller samples (being provided 
that all other conditions are equal) because larger sam-
ples minimize the probability of errors and maximize the 
accuracy and precision of the measurements. Second, 
we cannot consider that the procedure adopted in this 
study for pattern identification is absolutely concrete as 
until now there is no gold standard for the pattern iden-
tification in oriental medicine. Third, the obesity patterns 
identified in this study cannot be explained from the 
western medicinal point of view as the principle of orien-
tal medicine and conventional medicine are quite differ-
ent. Fourth, there was a time lag between completion of 
the study and writing, submission and peer review of the 
manuscript, all of which can be considerable.
Conclusion
In conclusion, our study can be considered as an evi-
dence-based approach providing a possible molecular 
explanation for obesity pattern differentiation practiced 
in oriental medicine. More specifically, our findings 
address a novel possibility that the genomic and oriental 
empirical approaches can be combined and implemented 
in systematic and synergistic development of personal-
ized medicine. In our study, gene clustering analysis of 
the microarray data of obese subjects exhibited disease 
pattern-specific upregulation of expression of several 
genes in a particular cluster. Even though we were able to 
identify five marker genes that were specifically expressed 
in PBMC of patients from LDS obesity pattern, further 
studies will allow to find more clear evidences that can 
segregate other oriental obesity patterns. Thus, our study 
can contribute to the understanding and development of 
personalized medicine based on oriental obesity pattern.
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